Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies.

[1]  Y. Hooks,et al.  Application of phage display to high throughput antibody generation and characterization , 2007, Genome Biology.

[2]  T. Wu.  The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune Evasion , 2007 .

[3]  Janice M Reichert,et al.  Handbook of therapeutic antibodies , 2007 .

[4]  T. Böldicke.  Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER , 2007, Journal of cellular and molecular medicine.

[5]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[6]  S. Dübel,et al.  Perspectives for systematic in vitro antibody generation. , 2005, Gene.

[7]  B. Heng,et al.  Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications. , 2005, Annals of clinical and laboratory science.

[8]  P. P. Mueller,et al.  Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR). , 2005, Journal of immunological methods.

[9]  R. Kontermann.  Intrabodies as therapeutic agents. , 2004, Methods.

[10]  A. Cattaneo,et al.  Intracellular antibodies for proteomics☆ , 2004, Journal of Immunological Methods.

[11]  Terry D. Foutz,et al.  Relationship between molecular and cellular dissociation rates for VLA-4/VCAM-1 interaction in the absence of shear stress. , 2004, Biophysical journal.

[12]  B. Goud,et al.  Recombinant Antibodies to the Small GTPase Rab6 as Conformation Sensors , 2003, Science.

[13]  S. Bodary,et al.  Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection , 2003, Expert opinion on biological therapy.

[14]  F. Breitling,et al.  Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli. , 2000, Protein engineering.

[15]  Martin R. Johnson,et al.  A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Andrew C. R. Martin,et al.  Fine mapping of the antigen–antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster , 1999, Journal of molecular recognition : JMR.

[17]  B. Engelhardt,et al.  The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. , 1998, The Journal of clinical investigation.

[18]  W. Marasco,et al.  Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat. , 1998, Human gene therapy.

[19]  M. Little,et al.  Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers. , 1994, Journal of immunological methods.

[20]  S. Chen,et al.  Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. J. Cashman,et al.  Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance , 1992, Annals of the New York Academy of Sciences.

[22]  L. Burkly,et al.  Cloning of murine and rat vascular cell adhesion molecule-1. , 1992, Biochemical and biophysical research communications.

[23]  M. Cybulsky,et al.  Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[25]  S. Munro,et al.  A C-terminal signal prevents secretion of luminal ER proteins , 1987, Cell.

[26]  David E. Gloriam,et al.  ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome , 2007, Nature Methods.

[27]  B. Heng,et al.  Making cell-permeable recombinant telomerase (trans-telomerase) through fusion of its catalytic subunit (hTERT) with protein transduction domains (PTD): a possible strategy to overcome replicative senescence during ex vivo culture of primary explanted cells. , 2005, Medical hypotheses.

[28]  S. Dübel,et al.  Mating antibody phage display with proteomics. , 2004, Trends in biotechnology.

[29]  S. Sharar,et al.  The adhesion cascade and anti-adhesion therapy: an overview , 2004, Springer Seminars in Immunopathology.

[30]  S. Dübel,et al.  Cloning single-chain antibody fragments (scFv) from hybridoma cells. , 2004, Methods in molecular medicine.

[31]  K. Mikoshiba,et al.  A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications , 2002, Nature Biotechnology.

[32]  W. Marasco,et al.  Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. , 1997, Annual review of microbiology.

[33]  Y. Tanaka,et al.  Lymphocyte interactions with endothelial cells. , 1992, Immunology today.